Member Info for VikR

Most people cannot comprehend the level this pro Ron Jon works at. He has a multi billion dollar level of thinking in his commercial ideas and once the viable products start income generating skeptics and the wider market will start taking notice fast.

Takes a certain mindset and level of experience to work on the level of Ron Jon- no doubt in my mind in the potential of this SP.

Expect many many multiples of the current SP this time next year

5 months into the DR5 project they must be progressing well and embedding some clinical findings by now. Cannot wait for the next update solely on this, another game changer for FAB.

DR5 massive commercial potential for bringing a therapeutic efficacious antibody to market. A lot of big pharma waiting on the sidelines for this one

Hi I qualified as a pharmacist in 2007 I then went back to university to get additional qualifications as an independent prescriber. I have then since been working in primary care in GP surgeries since seeing and prescribing for all types of patients from babies to elderly and everything in between. Luckily I have built a loyal patient base with my clinics booked months in advance with my regular patients. As a very passionate academic I have spent many years studying modern medicine and continue to do so. Alongside this I also own a substantive property portfolio, this is why I have been very fortunate to make sizable transactions across my shares portfolio. Some people find my combination hard to believe and question whether I am telling the truth. For avoidance of doubt anybody who wants to meet up I am going to the AGM meeting on 16/10 for fusion antibodies (another one of my investments) and flying to Belfast that weekend. Perhaps a F2F introduction would give my doubters more reassurance

Sorry for divulging but back to your q, which I have addressed in historical posts. Ph III failed (only just) to meet its primary endpoint and it has taken Seb et al a few years to go back to the drawing board and figure out following tweaks were needed:

) change route of administration to IV

) increase dose 10-15 fold to increase potency

) taper steroids before giving p14p to avoid interactions and reducing efficacy of p140

) perhaps the biggest discovery to date - p140 super responders. A subtype of patients that are more reciprocal to the biological effects of p140.

The latter point was not known during the first phase 3 trial but Seb et al made this phenomenal discovery in the last few years. It was this finding that was then externally validated by Jackson labs in USA. Anyone can say they have found a novel finding but to then have it examined externally that’s the biggest confirmation one can seek.

This is why I say you can no longer compare the failed trials to now as so much more is known since then and the MOA has since been identified, documented and is now being openly shared under NDAs with big Pharmas internal scientific team.

Historically we knew p140 worked but the scientists were not entirely sure how. We now know this in greater detail.

Call it luck, years of hard work or perseverance but these guys have finally elucidated the MoA

I have spent the last several days dissecting the videos and breaking down what Tim has discussed. As some members will know I am already a firm believer in the science behind p140 but wanted to apply a more holistic approach to my research and as always keep it evidence based.

Some things that stood out to to me is the comparables Tim has used to emphasise the commercial prowess of p140

Tim referred to the injectable biologic - Humira this was, once the world's best-selling drug, earning nearly $200 billion in sales for AbbVie since its 2002 approval. No doubt it has enjoyed a lot of success but just look at its side effect profile and immunosuppressive features shows how well p140 fares in comparison. Reference below

https://www.nhs.uk/medicines/adalimumab/about-adalimumab/

Next comparable that was used was the recently repurposed GLP-1 injectables for weight loss originally used for diabetes. Analysts project substantial market growth for these drugs, with figures ranging from approximately $90 billion to over £150-200 billion by 2030( reference below FYI). Tim highlighted how transformational p140 could be and has confidently given TWO relevant market leading examples as direct comparable’s to quantify the scale of commercialization.

https://www.grandviewresearch.com/industry-analysis/glp-1-agonists-weight-loss-drugs-market-report

These are very bold claims to be able to even have the confidence to pitch your own product against market leaders. No one has coerced him into making these comparisons but such his own belief and rightly so in the future trajectory of p140.

Now back to the multiple videos that have been released recently and the most recent from 10 days ago the message has been consistent throughout without any ambiguity or doubt. I’m not sure how many times the poor chap needs to repeat the same message. Everyone needs to put there bitter historical experiences to one side and move to the future. P140 is here and now and what has happened in the past is now irrelevant as a new chapter arises.

Tim also disclosed he himself suffers from an under active thyroid gland and took him nearly 2 years to get diagnosed. I would agree with this statement having worked in general practice for 17 years and also a visiting lecturer at my local uni, auto immune diseases are amongst the hardest to diagnose. They can present with vague constitutional symptoms making it difficult to get a timely diagnosis. If p140 conquers the diagnostic market with its super responder blood test it will be a big win for modern medicine around the globe. If a patient comes to see my and I can triage that patient and offer them a p140 blood test if I am worried about an auto immune condition both me and the patient win in our concordant interaction.

In summary whatever happens to the SP between now and deal announcement does not hinder the end goal.

If you piece all the information together thus far P140 is going to change the landscap

Just had a message on the HL app alluding to the same. Does this mean that we will get new shares allocated to our account on top of the ones we hold on a 10:1 ratio ?

Thanks

Good riddance pal

This has tremendous potential and when it re rates it will do so exponentially. Even if one idea doesn’t prove to be as lucrative there’s too many incubations for it to fail

Good opportunity to increase the holdings whilst this has been hovering for a few weeks. Can only really go one way now and each day is closer to the farm out announcement.

One to stock up and hold

Will try and recycle some more profits elsewhere to bring here to continue accumulating

Wholeheartedly agree with your sentiment

How one can even contemplate selling at these levels is shocking. With all the multiple licensing agreements that have been executed and the Silicon valley collaboration are investors really blind to all this. We all know more joint ventures are forthcoming along the way and further ideas to be incubated. I suppose it gives me more opportunity to recycle funds from elsewhere whilst it fluctuates at these levels

Strong buy and hold

Brought at 1.23p

Confident now to continue building on my holdings with the latest TR1. Trying to recycle profits from elsewhere to bring more into here , if I make any more sizeable purchases il post it on here

Stake building is the best play for this one now IMP

Im around 7 million at the moment on my account, in the red for now but definitely holding for the greater good

Fundamentals remain intact and they have stuck to there word every step of the way. Not long before revenue generation begins and new services get launched concomitantly.

Prof Ron Jon knows what he is doing and will be driving this to success. The next few positive RNSs and everyone will come flying in, best to get in before the herd at these here current levels

Strong hold astute investors

Great RNS and takes out more shares of the game leaving less for manipulation with the MMs onwards and upwards

Excellent buy here continues

Childish but believable given the historical nature of your posts to date, best of luck for the future. Let us not engage any further as I don’t wish to waste my valuable time on your negativity and foolishness.

Thanks for your comments I take them on board, I am not a millionaire I am fortunate to be a multi millionaire. Do you wish to see my bank statements/ car or house as evidence ?

I graduated as a pharmacist some 17 years ago but also invested in property alongside which remains a lucrative source of income for me and has served me very well over the years. This profit then gets ploughed into shares I believe in such as IMM. I am not the brightest person in the room but I would like to think I have some academic and business acumen to make constructive evidence backed statements.

A deal to be done is public knowledge as has been alluded to many a time thus far , I’m just reinforcing what the BoD are doing in the background. Some imbeciles however expect;

Patent applied

Deal to be announced a week later

Get realistic with your timelines and don’t use the down period to spread fear and misguided information.

One2many your entire modus operandi is one of spreading fear/doubt and none of your counter arguments present any evidence base and seem to be mere anecdotal miserable sentences.

Hope these board members can decipher genuine, honest and transparent posts. I wish well for everyone including you sir.

The next few months present a remarkable opportunity for significant news flow which will help this SP rocket. Target number 1 on the upward trajectory will be 50p for the first pit stop. Thereafter the potential is uncapped dependent on the level of deals to be done.

Dr Ho has personally endorsed optimal thus far which is the highest honour one can ask for in this field. Take a look at his credentials below to get an idea of the calibre of this gentleman, he has been with NCI since 2008 and won numerous international awards:

In 2024 he won the Asian American engineer of the year award 🥇

Dr. Ho is also the Director of the NCI CCR Antibody Engineering Program. Anything to do with cancer immunotherapy for whichever cancer Prof Ho is the man in the know how.

He wants to be associated with the best antibodies in the world with the most EFFICACY and REPRODUCIBILITY- Optimal’s signature

https://www.antibodysociety.org/about/board-of-directors/mitchell-ho-ph-d/

Having seen what has happened at WSBN today, the opportunity here is remarkable. In the interests of transparency I did buy into WSBN a few weeks ago and made a decent sum today. Before the RNS gets launched will recycle some profits into here to hopefully take advantage of a similar/better rise. I’m glad I have steadily held this over the last few months and can now see blue on my ISA and fund and share account respectively.

Strong buy and hold with current pipeline in situ

Lisa has made it clear when I spoke to her last that multiple Pharma are engaged in constructive talks and the proposed timeline is very much an important one for 2 reasons, one for the wider market itself and number 2 to prompt big pharma into deciding what they are willing to offer on p140 without dragging this to a never ending conclusion.

Now the due diligence is very much a complex one especially more so with p140 simply because it has so many wide applications for different auto immune conditions, one has to decide the value as an overall and that’s excluding its diagnostic capability.

IMM don’t have a middle man to broker the deal so they are in direct discussions with multiple interested parties - this has been confirmed

The whole process is extremely complex when compared to a single drug to license with a single indication for therapeutic treatment excluding diagnosis. P140 as a peptide has so many branches for potential this complicates the financials of the deal.

In conclusion I can’t vouch for what the SP will do between now and the deal landing, but if you can afford to be patient and hold during this period please expect a massive Rerate from where we are currently sitting. If you can imagine what a patent grant has done to this SP just imagine when the partnership licensing agreement gets announced.

As always it is imperative to ignore the noise and focus on the end result. I still remember the same derampers back in Summer ridiculed my theories off this board and I stopped posting. We hit 1.5p during that stage but the fundamentals were still intact it was just the sentiment and trust that had been compromised. We now have the strongest fundamentals we have ever had and for those who still don’t believe Tim, just look at Dr Sebastian’s comments and the fact Jackson labs has INDEPENDENTLY verified every single finding.

In your heart of hearts I sincerely hope you are able to make an evidence based informed decision whether you wish to buy and hold or simply eject at this stage.

Either way I wish you well on your prospective journey

Only brought into this share 2 weeks ago now just under 2 million holding. Hoping it has a lot more traction towards shooting up. Wasn’t expecting this to multibag but if they prove the resource and get further success this will shoot up.

Early days but everything thus far is pointing towards a good outcome

Some sizeable transactions being conducted, as the saying goes follow the smart money and big buys.

Exciting times to see the next round of RNSs to drop

Haven’t added any more yet but definitely won’t be selling a single share

Thanks for doing your bit for the community and humanity.

Very noble of you to warn people from making too much money from possibly what will be the biggest turnaround share of 2025.